Avatar Intervention for Cannabis Use Disorder in Individuals with Severe Mental Disorders: A Pilot Study.
addiction intervention
cannabis use disorder
mood disorder
psychotic disorder
relational therapy
virtual reality therapy
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
29 Apr 2023
29 Apr 2023
Historique:
received:
26
03
2023
revised:
22
04
2023
accepted:
27
04
2023
medline:
27
5
2023
pubmed:
27
5
2023
entrez:
27
5
2023
Statut:
epublish
Résumé
Cannabis use disorder (CUD) is a complex issue, even more so when it is comorbid with a severe mental disorder (SMD). Available interventions are at best slightly effective, and their effects are not maintained over time. Therefore, the integration of virtual reality (VR) may increase efficacy; however, it has not yet been investigated in the treatment of CUD. A novel approach, avatar intervention for CUD, uses existing therapeutic techniques from other recommended therapies (e.g., cognitive behavioral methods, motivational interviewing) and allows participants to practice them in real-time. During immersive sessions, participants are invited to interact with an avatar representing a significant person related to their drug use. This pilot clinical trial aimed to evaluate the short-term efficacity of avatar intervention for CUD on 19 participants with a dual diagnosis of SMD and CUD. Results showed a significant moderate reduction in the quantity of cannabis use (Cohen's d = 0.611,
Identifiants
pubmed: 37240936
pii: jpm13050766
doi: 10.3390/jpm13050766
pmc: PMC10223054
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : IRSC Catayseur
ID : CRS-2021-118
Organisme : Services et recherches psychiatriques AD
ID : NA
Organisme : Fondation Lévesque
ID : NA
Références
Schizophr Res. 2021 Feb;228:229-234
pubmed: 33461022
Int J Methods Psychiatr Res. 2018 Mar;27(1):
pubmed: 29034525
Res Soc Work Pract. 2012 May;22(3):293-300
pubmed: 25484549
Psychiatry Res. 1988 Jan;23(1):99-110
pubmed: 3363019
Drug Alcohol Depend. 2006 Jun 9;83(1):42-8
pubmed: 16289930
Addiction. 2021 May;116(5):1000-1010
pubmed: 33160291
J Stud Alcohol Drugs. 2009 Jul;70(4):516-27
pubmed: 19515291
Nat Rev Dis Primers. 2021 Feb 25;7(1):16
pubmed: 33627670
Psychol Med. 2022 Aug;52(11):2001-2008
pubmed: 35855651
J Subst Abuse Treat. 2017 Oct;81:53-58
pubmed: 28847455
Clin Chem. 2002 Feb;48(2):301-6
pubmed: 11805011
J Affect Disord. 2020 Apr 1;266:258-262
pubmed: 32056886
Biol Psychiatry. 2005 Mar 15;57(6):594-608
pubmed: 15780846
J Affect Disord. 2021 Feb 15;281:467-475
pubmed: 33360749
Schizophr Res. 2018 Jul;197:176-181
pubmed: 29486956
Front Neurosci. 2020 Jan 10;13:1409
pubmed: 31998066
Schizophr Res. 2020 Oct;224:40-44
pubmed: 33183946
Addiction. 2012 Jun;107(6):1123-31
pubmed: 22151583
Clin Psychol Rev. 2017 Nov;57:195-207
pubmed: 28781153
Addict Behav. 2015 Oct;49:59-63
pubmed: 26047836
Health Aff (Millwood). 2016 Jan;35(1):12-9
pubmed: 26733696
Addict Behav. 2023 Apr;139:107578
pubmed: 36563480
J Subst Abuse Treat. 2019 Jan;96:26-32
pubmed: 30466545
Addiction. 2022 Jan;117(1):172-181
pubmed: 34142398
Psychol Addict Behav. 2014 Mar;28(1):154-62
pubmed: 23276315
Cochrane Database Syst Rev. 2019 Jan 28;1:CD008940
pubmed: 30687936
Psychiatr Serv. 2008 Mar;59(3):276-82
pubmed: 18308908
Cyberpsychol Behav Soc Netw. 2010 Apr;13(2):159-62
pubmed: 20528271
Can J Psychiatry. 2013 Nov;58(11):646-9
pubmed: 24246436
Indian J Psychiatry. 2003 Jul;45(3):182-8
pubmed: 21206852
Cyberpsychol Behav Soc Netw. 2014 Apr;17(4):262-7
pubmed: 24555521
Subst Use Misuse. 2022;57(5):719-729
pubmed: 35170396
Drug Alcohol Rev. 2020 May;39(4):337-346
pubmed: 32291811
Front Hum Neurosci. 2014 Oct 17;8:844
pubmed: 25368571
J Affect Disord. 2015 Jan 15;171:39-47
pubmed: 25285897
Psychopharmacol Bull. 2020 May 19;50(2):56-67
pubmed: 32508368
Adv Exp Med Biol. 2021;1264:67-80
pubmed: 33332004
Clin Psychol Rev. 2022 Dec;98:102213
pubmed: 36356351
Acta Psychiatr Scand. 2006 Aug;114(2):109-17
pubmed: 16836598
Addiction. 2022 Jul;117(7):1857-1870
pubmed: 35048456
Int J Drug Policy. 2021 Nov;97:103295
pubmed: 34062288
Int J Methods Psychiatr Res. 2020 Mar;29(1):e1813
pubmed: 31808250
Rev Mal Respir. 2014 Jun;31(6):488-98
pubmed: 25012035
Addiction. 2018 Oct;113(10):1905-1926
pubmed: 29749059
Drug Alcohol Depend. 2018 Oct 1;191:234-258
pubmed: 30153606
Psychiatr Serv. 2012 Jul;63(7):666-71
pubmed: 22588167
Neuropsychopharmacology. 2018 Jan;43(1):173-194
pubmed: 28875989
Health Promot Chronic Dis Prev Can. 2020 Jun;40(5-6):176-183
pubmed: 32529977
Psychiatr Serv. 2009 Jan;60(1):50-5
pubmed: 19114570
Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005336
pubmed: 16856093
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Schizophr Res. 2013 Jan;143(1):138-42
pubmed: 23187069
Subst Abuse. 2018 Feb 28;12:1178221818760551
pubmed: 29531472
Neurosci Biobehav Rev. 2019 Aug;103:14-20
pubmed: 31121199
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):107-120
pubmed: 30564886
Cyberpsychol Behav. 2009 Oct;12(5):477-83
pubmed: 19817561
Psychother Psychosom. 2011;80(5):287-97
pubmed: 21646823
Nicotine Tob Res. 2015 Jul;17(7):796-802
pubmed: 25475087
Drug Alcohol Depend. 2012 Mar 1;121(3):247-52
pubmed: 21955364
Exp Clin Psychopharmacol. 2000 Nov;8(4):509-17
pubmed: 11127422
Psychol Med. 2017 Oct;47(14):2393-2400
pubmed: 28325167
Am J Drug Alcohol Abuse. 2022 Nov 2;48(6):631-643
pubmed: 36137273
Cureus. 2021 Jul 29;13(7):e16722
pubmed: 34513357
Addict Behav. 2013 Oct;38(10):2551-4
pubmed: 23793042
Addict Behav. 2023 Mar;138:107552
pubmed: 36413909
J Psychiatr Res. 2021 Nov;143:516-527
pubmed: 33248674
Eur Addict Res. 2021;27(6):413-427
pubmed: 33965941
Subst Use Misuse. 2022;57(9):1470-1477
pubmed: 35754378
Br J Psychiatry. 2006 May;188:439-48
pubmed: 16648530
PLoS One. 2015 Mar 04;10(3):e0118916
pubmed: 25738578
JAMA Psychiatry. 2019 Apr 1;76(4):426-434
pubmed: 30758486
N Engl J Med. 2014 Jun 5;370(23):2219-27
pubmed: 24897085
Addiction. 2010 Apr;105(4):615-25
pubmed: 20403014
Psychiatry Res. 2015 Dec 15;230(2):341-9
pubmed: 26388103
J Nerv Ment Dis. 2009 Jan;197(1):35-40
pubmed: 19155808
Lancet Psychiatry. 2020 Apr;7(4):344-353
pubmed: 32197092
Schizophr Bull. 1984;10(3):388-98
pubmed: 6474101
Neurosci Biobehav Rev. 2019 Jun;101:78-84
pubmed: 30974123
Addiction. 2006 Oct;101(10):1479-92
pubmed: 16968350
Front Psychiatry. 2022 May 12;13:842329
pubmed: 35633799
Restor Dent Endod. 2017 May;42(2):152-155
pubmed: 28503482
Psychiatry Res. 2022 Jan;307:114338
pubmed: 34922239
Addict Behav. 2009 Jun-Jul;34(6-7):520-5
pubmed: 19268481
Prev Med. 2017 Nov;104:13-23
pubmed: 28705601
NPJ Schizophr. 2021 Feb 12;7(1):9
pubmed: 33580033
Curr Opin Psychol. 2021 Oct;41:40-45
pubmed: 33714892
Addict Behav. 2006 Oct;31(10):1881-94
pubmed: 16516397
Behav Res Ther. 2015 Nov;74:18-24
pubmed: 26355646
J Subst Abuse Treat. 2006 Jun;30(4):291-5
pubmed: 16716843
Addict Behav. 2008 Jun;33(6):743-56
pubmed: 18282663
Complement Ther Med. 2020 Aug;52:102480
pubmed: 32951730
Clin Psychol Psychother. 2021 May;28(3):519-537
pubmed: 34048621